List of SmartCells patents | 5 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8729242 Methods for reducing the mitogenicity of lectin compositions	Patent 8729242 was granted and assigned to SmartCells on May, 2014 by the United States Patent and Trademark Office.	SmartCells	United States Patent and Trademark Office	8729242	May 20, 2014
‌ US Patent 8697643 Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator	Patent 8697643 was granted and assigned to SmartCells on April, 2014 by the United States Patent and Trademark Office.	SmartCells	United States Patent and Trademark Office	8697643	April 15, 2014
‌ US Patent 8623345 Terminally-functionalized conjugates and uses thereof	Patent 8623345 was granted and assigned to SmartCells on January, 2014 by the United States Patent and Trademark Office.	SmartCells	United States Patent and Trademark Office	8623345	January 7, 2014
‌ US Patent 8906850 Crystalline insulin-conjugates	Patent 8906850 was granted and assigned to SmartCells on December, 2014 by the United States Patent and Trademark Office.	SmartCells	United States Patent and Trademark Office	8906850	December 9, 2014
‌ US Patent 9050370 Conjugate based systems for controlled drug delivery	Patent 9050370 was granted and assigned to SmartCells on June, 2015 by the United States Patent and Trademark Office.	SmartCells	United States Patent and Trademark Office	9050370	June 9, 2015